Back to Results
First PageMeta Content
Bristol-Myers Squibb / Pharmacology / Organofluorides / Non-nucleoside reverse transcriptase inhibitors / Purines / Tenofovir / Emtricitabine/tenofovir/efavirenz / Efavirenz / Reverse-transcriptase inhibitor / Chemistry / Organic chemistry / Gilead Sciences


ATRIPLA™ (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets ℞ Only WARNING LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS,
Add to Reading List

Document Date: 2006-09-17 23:43:36

Open Document

File Size: 265,31 KB

Share Result on Facebook

Currency

pence / /

Event

Product Issues / /

IndustryTerm

HEPATITIS B THERAPY / chemical / food / /

MedicalCondition

DF / HIV / HBV / renal insufficiency / /

Position

RT / HIV RT / /

Product

efavirenz / EMTRIVA / zidovudine / tenofovir disoproxil fumarate / talc / estradiol / azithromycin / SUSTIVA / famotidine / TRUVADA / nevirapine / Carbamazepine / polyethylene glycol / lorazepam / abacavir / lamivudine / VIREAD / Clarithromycin / didanosine / adenosine / ATRIPLA / Rifampin / fluconazole / stavudine / /

Technology

Pharmacokinetics / /

SocialTag